These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29162718)

  • 61. Clinically relevant test methods to establish in vitro equivalence for spacers and valved holding chambers used with pressurized metered dose inhalers (pMDIs).
    Mitchell J; Dolovich MB
    J Aerosol Med Pulm Drug Deliv; 2012 Aug; 25(4):217-42. PubMed ID: 22857273
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical comparability between the CFC and HFA budesonide pressurised metered-dose inhalers in paediatric patients with asthma: a randomised controlled trial.
    Escribano A; Tutuncu A; Löhr I; Carlholm M; Polanowski T
    Curr Med Res Opin; 2006 Jun; 22(6):1085-92. PubMed ID: 16846541
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fluticasone propionate HFA-134a pressurized metered-dose inhaler in adolescents and adults with moderate to severe asthma.
    Pinnas JL; Noonan MJ; Weinstein SF; Chervinsky P; Scott CA; Herje NE; Wu W; Crim C
    J Asthma; 2005 Dec; 42(10):865-71. PubMed ID: 16393726
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The evolution of spacers and valved holding chambers.
    Nikander K; Nicholls C; Denyer J; Pritchard J
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27 Suppl 1():S4-23. PubMed ID: 25054481
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma.
    Murphy K; Nelson H; Parasuraman B; Boggs R; Miller C; O'Dowd L
    Curr Med Res Opin; 2008 Mar; 24(3):879-94. PubMed ID: 18267051
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study.
    Jones R; Martin J; Thomas V; Skinner D; Marshall J; Stagno d'Alcontres M; Price D
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2445-2454. PubMed ID: 28860739
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients.
    Busse WW; Shah SR; Somerville L; Parasuraman B; Martin P; Goldman M
    J Allergy Clin Immunol; 2008 Jun; 121(6):1407-14, 1414.e1-6. PubMed ID: 18455221
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bronchodilation of formoterol administered with budesonide: device and formulation effects.
    Miller CJ; Senn S; Mezzanotte WS
    Contemp Clin Trials; 2008 Mar; 29(2):114-24. PubMed ID: 17625985
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Aerosol therapy by pressured metered-dose inhaler-spacer in sleeping young children: to do or not to do?
    Esposito-Festen J; Ijsselstijn H; Hop W; van Vliet F; de Jongste J; Tiddens H
    Chest; 2006 Aug; 130(2):487-92. PubMed ID: 16899849
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.
    Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H
    J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Asthma pressurised metered dose inhaler performance: propellant effect studies in delivery systems.
    Sellers WFS
    Allergy Asthma Clin Immunol; 2017; 13():30. PubMed ID: 28670327
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Imperative Instruction for Pressurized Metered-Dose Inhalers: Provider Perspectives.
    Schmitz DC; Ivancie RA; Rhee KE; Pierce HC; Cantu AO; Fisher ES
    Respir Care; 2019 Mar; 64(3):292-298. PubMed ID: 30254041
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Respirable dose delivery of fluticasone propionate from a small valved holding chamber, a compact breath actuated integrated vortex device and a metered dose inhaler.
    Nair A; Menzies D; Barnes M; Burns P; McFarlane L; Lipworth BJ
    Br J Clin Pharmacol; 2008 Jul; 66(1):20-6. PubMed ID: 18341676
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Inhalation therapy in asthma: nebulizer or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children.
    Wildhaber JH; Dore ND; Wilson JM; Devadason SG; LeSouëf PN
    J Pediatr; 1999 Jul; 135(1):28-33. PubMed ID: 10393600
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial.
    Zangrilli J; Mansfield LE; Uryniak T; O'Brien CD
    Ann Allergy Asthma Immunol; 2011 Sep; 107(3):258-65.e2. PubMed ID: 21875546
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Salbutamol delivery from a hydrofluoroalkane pressurized metered-dose inhaler in pediatric ventilator circuits: an in vitro study.
    Wildhaber JH; Hayden MJ; Dore ND; Devadason SG; LeSouëf PN
    Chest; 1998 Jan; 113(1):186-91. PubMed ID: 9440589
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Systemic exposure and urinary cortisol effects of fluticasone propionate formulated with hydrofluoroalkane in 4- to 11-year-olds with asthma.
    Kim KT; Milgrom H; Yoon YK; Levy AL; Matz P; Welch MJ; Cahn A; Collins DA; Kathman S; Mehta R; Su SF; Kunka RL
    J Clin Pharmacol; 2008 Jan; 48(1):108-16. PubMed ID: 18094223
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Device type and real-world effectiveness of asthma combination therapy: an observational study.
    Price D; Roche N; Christian Virchow J; Burden A; Ali M; Chisholm A; Lee AJ; Hillyer EV; von Ziegenweidt J
    Respir Med; 2011 Oct; 105(10):1457-66. PubMed ID: 21612903
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical equivalence of budesonide dry powder inhaler and pressurized metered dose inhaler.
    Srichana T; Juthong S; Thawithong E; Supaiboonpipat S; Soorapan S
    Clin Respir J; 2016 Jan; 10(1):74-82. PubMed ID: 25043636
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
    Dusser D; Vicaut E; Lefrançois G;
    Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.